• 11 December 2012

    INDIAN PHARMA : RAISING BAROMETER OF SUCCESS BEYOND GENERICS

    About Authors:
    Ritul bapna
    LMC of science and technology,
    Jodhpur
    *bapnaritul89@gmail.com

    1. Introduction
    The principal law for patenting system in India is the Patents Act, 1970. Initially, according to the provisions of this law no product patent but only process patents could be granted for inventions relating to food, drugs and chemicals. However, since 2005 product patenting is allowed in India. India being a member country of World Trade Organization (WTO) signed TRIPS (Trade Related Aspects of Intellectual Property Rights) Agreement in laws to be followed by each of its member countries. India being a signatory of the TRIPS agreement was under a contractual obligation to amend its Patents law to make it compliant with the provisions of the agreement. The first amendment in this series was in the form of the Patents (Amendment) Act, 1999 to give a pipeline protection till the country starts giving product patents. It laid down the provisions for filing of applications for product patents in the field of drugs and agrochemicals with effect from 1st January1995 as mailbox applications and introduced the grant of Exclusive Marketing Rights (EMRs) on those patents. To comply with the second set of TRIPS obligations India further amended the Patents Act, 1970 by the Patents (Amendment) Act, 2002.Through this amendment provision of 20 years uniform term of patent for all categories of invention was introduced. The third set of amendments in the patent law was introduced as the Patents (Amendment) Act, 2005. Through this amendment product patent regime was introduced in India. To implement its TRIPS obligations, India passed changes to its patent law in 2005 so that medicines could now be patented. However, the new law also contained the flexibilities. India has one of the best patent laws in the world in terms of giving some space to its producers to make generic medicines.

  • Area Sales Manager require in Synergy Diagnostics | All India Level
    11 November 2012
    Area Sales Manager require in Synergy Diagnostics | All India Level

    Synergy Diagnostics pvt Ltd, a Bio-pharmaceutical company, with the Largest range of human blood plasma derived bio-pharmaceutical products, used in the prophylaxis & treatment of various life-threatening conditions.We are basically in to Sales & Marketing of imported products Manufactured from Human Blood. Products manufactured are injectable & critical care products.

  • Work as Area sales Executive/Medical representative in Synergy Diagnostics - Freshers may apply
    8 November 2012
    Work as Area sales Executive/Medical representative in Synergy Diagnostics - Freshers may apply

    Synergy Diagnostics pvt Ltd, a Leading Bio-pharmaceutical company, with the Largest range of human blood plasma derived bio-pharmaceutical products, used in the prophylaxis & treatment of various life-threatening conditions.We are basically in to Sales & Marketing of imported products Manufactured from Human Blood. Products manufactured are injectable & critical care products.

  • STEM CELLS AND PEPTIDES TO BRAIN VIA INTRASNASAL ROUTE
    30 September 2012
    STEM CELLS AND PEPTIDES TO BRAIN VIA INTRASNASAL ROUTE

    About Authors:
    Ms.Pratibha Chohan*, Mr.Prashant Mutha
    B.Pharmacy, G. D. Memorial College of Pharmacy, Jodhpur.
    *pmuthabiotech@gmail.com

    ABSTRACT:
    Brain is tightly segregated from the circulating blood by a unique membranous barrier, the blood – brain barrier (BBB). Many pharmaceuticals cannot be efficiently delivered to, or sustained within the brain; hence they are ineffective in treating a plethora of cerebral diseases. Therefore, drug delivery methods that can provide drug delivery to brain or eventually preferential brain delivery (i.e. brain targeting) are of particular interest. One technique that holds promise for bypassing the BBB to deliver drugs to the brain and eliminating the surgical risk and the spillover effect of drug to normal tissue is the intranasal delivery.

    [adsense:336x280:8701650588]

  • Applications are invited for the positions of Hired contract based Researchers in G.B. Pant Institute of Himalayan Environment and Development
    28 September 2012
    Applications are invited for the positions of Hired contract based Researchers in G.B. Pant Institute of Himalayan Environment and Development

    G.B. Pant Institute of Himalayan Environment and Development (GBPIHED) was established in 1988-89, during the birth centenary year of Bharat Ratna Pt. Govind Ballabh Pant, as an autonomous Institute of the Ministry of Environment and Forests (MoEF), Govt.

  • Fresher M.Pharm, M.Sc, B.Pharm, B.Sc invited for Marketing Executives, Marketing Managers, Formulation Development in Olefia Biopharma - more than 100 vacancies
    7 June 2012
    Fresher M.Pharm, M.Sc, B.Pharm, B.Sc invited for Marketing Executives, Marketing Managers, Formulation Development in Olefia Biopharma - more than 100 vacancies

    Olefia Biopharma Limited, We would like to introduce ourselves as one of the most rapidly emerging FMCG Company in various fields of Pharmaceutical, Cosmetics, Ayurvedics / herbals and biotech.
    Olefia Biopharma Limited is utilising MHRA and WHO-GMP Approved manufacturing unit to manufacture various Tablets, Capsule, Syrups, Suspensions and other formulations for its various division viz. Pharmaceutical and Cosmetic i.e. FMCG and exporting to various countries across the Globe.

  • A Client of Aple Pharma require Medical Representative & Area Manager | Multiplace Vacancies
    30 May 2012
    A Client of Aple Pharma require Medical Representative & Area Manager | Multiplace Vacancies

    A leading Pharmaceutical Company requires Medical Representative at all the major HQ's in India.

    Post: Medical Representative & Area manager

    [adsense:336x280:8701650588]

  • Opening in pharma sales as MR/DSM & Area Sales Manager - Nextus
    17 April 2012
    Opening in pharma sales as MR/DSM & Area Sales Manager - Nextus

    The company manufactures active pharmaceutical ingredients (APIs or bulk actives). In addition, it has several pharma products that address relevant and growing therapeutic areas like gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives and pain management among others.

  • Opening for MR/MT in Pharmaceutical company producing a wide range of quality, affordable generic and branded formulations
    5 April 2012
    Opening for MR/MT in Pharmaceutical company producing a wide range of quality, affordable generic and branded formulations

    Pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs for the developed and developing markets of the world.

    Post: MR/MT

    [adsense:336x280:8701650588]

  • Spectrophotometric Methods for Simultaneous Estimation Of Pyrimethamine And Sulphadoxine In Bulk Drug And Pharmaceutical Formulations
    20 January 2012
    Spectrophotometric Methods for Simultaneous Estimation Of Pyrimethamine And Sulphadoxine In Bulk Drug And Pharmaceutical Formulations

    About Authors:
    Kalpesh N. Patel1*, Jayvadan K. Patel2
    1 Research Scholar, Jodhpur National University, Jodhpur,
    Rajshathan, India
    2 Department of Pharmaceutical Technology,
    Nootan Pharmacy College,
    Visnagar (GUJARAT), India.

    Abstract
    Two simple spectrophotometric methods have been developed for simultaneous estimation of pyrimethamine and sulphadoxine from tablet dosage form. Method-I simultaneous equation method involves the measurement of absorbances at two wavelengths 215 nm (λmax of pyrimethamine) and 254 nm (λmax of sulphadoxine) in methanol and Method-II first order derivative spectroscopic method involves the measurement of absorbances at two wavelengths 250 nm (λmax of pyrimethamine) and 220.5 nm (λmax of sulphadoxine); The linearity lies between 5-30 µg/ml for both pyrimethamine and sulphadoxine for all the two methods. The accuracy and precision of the methods were determined and validated stastically. All the methods showed good reproducibility and recovery with % RSD less than 2. All method were found to be rapid, specific, precise and accurate and can be successfully applied for the routine analysis of pyrimethamine and sulphadoxine in bulk and combined dosage form.

Subscribe to Jodhpur